Compare ORBS & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORBS | MOBI |
|---|---|---|
| Founded | 1966 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 447.0M | 383.0M |
| IPO Year | 2022 | 2026 |
| Metric | ORBS | MOBI |
|---|---|---|
| Price | $0.67 | $13.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 12.5M | 179.7K |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,820,779.00 | N/A |
| Revenue This Year | N/A | $71.88 |
| Revenue Next Year | N/A | $43.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.57 | $8.03 |
| 52 Week High | $3.62 | $15.19 |
| Indicator | ORBS | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 38.62 | 67.66 |
| Support Level | $0.60 | $10.70 |
| Resistance Level | $0.88 | $13.85 |
| Average True Range (ATR) | 0.06 | 1.14 |
| MACD | -0.00 | 0.28 |
| Stochastic Oscillator | 9.67 | 85.93 |
Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Corrugated Packaging Business manufactured and sold custom packaging for a wide products and through packaging helps customers generate brand awareness and promote brand image. Generate the substantial majority of revenues from inventory financing and inventory management services.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.